novel
viru
name
novel
coronaviru
caus
syndrom
symptom
classifi
coronaviru
diseas
first
describ
among
caseseri
patient
visit
local
market
chines
citi
wuhan
decemb
viru
first
isol
januari
sinc
spread
around
world
recent
estim
april
reveal
current
confirm
case
death
recent
publish
metaanalysi
examin
frequenc
symptom
human
investig
describ
among
common
symptom
fever
cough
muscl
achesfatigu
dyspnea
headach
sore
throat
gastrointestin
symptom
addit
aforement
common
clinic
symptom
investig
describ
detail
chest
imag
result
among
chest
radiolog
examin
common
abnorm
opac
bilater
unilater
without
pleural
effus
multipl
groundglass
opac
infiltr
among
undergo
comput
tomographi
ct
scan
common
abnorm
observ
groundglass
opac
accompani
septal
thicken
infiltr
abnorm
parenchym
consolid
small
number
person
observ
normal
chest
radiograph
ct
find
investig
describ
radiolog
examin
reveal
groundglass
opac
covid
distribut
interestingli
patient
observ
present
lung
cavit
discret
pulmonari
nodul
pleural
effus
lymphadenopathi
final
patient
undergo
autopsi
show
bilater
diffus
alveolar
damag
associ
pulmonari
edema
proinflammatori
concentr
indic
earlyphas
acut
respiratori
distress
syndrom
ard
clinic
examin
sever
case
reveal
decreas
ratio
arteri
oxygen
partial
pressur
fraction
inspir
oxygen
pao
fio
ratio
concomit
hypoxia
tachypnea
addit
investig
describ
low
carbon
dioxid
co
carbon
dioxid
level
median
partial
pressur
carbon
dioxid
paco
level
mmhg
short
hypoxia
hypocapnia
seen
sever
case
even
postul
recent
base
upon
analyz
clinic
data
report
publish
studi
strike
similar
high
altitud
pulmonari
edema
hape
manifest
acut
hypox
ventilatori
respons
research
observ
follow
similar
arteri
oxygen
partial
pressur
fraction
inspir
oxygen
ratio
decreas
hypoxia
present
tachypnea
increas
partial
pressur
carbon
dioxid
level
decreas
ground
glass
opac
chest
ct
present
patchi
infiltr
chest
xray
present
fibrinogen
levelsfibrin
format
increas
alveolar
compris
present
ard
develop
sever
diseas
present
current
gener
recogn
effect
treatment
urgent
need
given
breadth
scope
diseas
present
antivir
medic
vaccin
earli
development
stage
may
take
mani
month
even
year
fulli
develop
result
imper
consid
novel
new
therapeut
intervent
necessarili
cure
underli
diseas
instead
provid
support
care
help
assist
patient
surviv
especi
given
potenti
induc
respiratori
condit
associ
signific
mortal
respiratori
condit
import
describ
one
hallmark
critic
cours
develop
ard
ard
lead
low
blood
oxygen
level
directli
lifethreaten
bodi
organ
depend
upon
adequ
oxygen
blood
order
fulli
understand
ard
import
consid
lung
function
one
breath
air
taken
nose
mouth
pass
windpip
alveoli
within
lung
capillari
run
alveoli
oxygen
pass
blood
stream
carri
part
bodi
ard
capillari
within
lung
leak
fluid
normal
alveoli
prevent
lung
deliv
enough
oxygen
blood
stream
consequ
bodi
organ
work
poorli
fig
summar
deliveri
hemoglobinbas
oxygen
molecul
peripher
tissu
normal
patient
capillari
patient
capillari
support
manag
respiratori
ventil
support
standard
therapeut
treatment
recent
metaanalysi
identifi
use
supplementari
oxygen
therapi
invas
ventil
even
extracorpor
membran
oxygen
ecmo
treatment
surprisingli
high
among
identifi
patient
kind
pharmacolog
andor
support
intervent
report
unfortun
regard
standard
ventil
support
patient
observ
cohort
patient
admit
intens
care
unit
icu
given
noninvas
ventil
icu
admiss
requir
orotrach
intub
invas
mechan
ventil
icu
mortal
rate
among
requir
noninvas
ventil
among
requir
invas
mechan
ventil
moral
rate
current
standard
respiratori
treatment
employ
among
patient
base
upon
longestablish
treatment
protocol
viral
pneumonia
sinc
patholog
observ
patient
unlik
viral
pneumonia
understand
current
employ
therapi
highli
ineffect
follow
section
hypothes
seri
altern
treatment
strategi
treat
respiratori
condit
significantli
improv
tissu
oxygen
among
patient
hyperbar
oxygen
therapi
hyperbar
oxygen
therapi
hbot
treatment
design
increas
oxygen
level
blood
patient
either
sit
lie
enclos
chamber
pressur
rais
chamber
oxygen
administ
hobt
pressur
express
multipl
atmospher
pressur
sea
level
atmospher
atmospher
psi
kg
per
cm
kpa
torr
mm
hg
sea
level
blood
plasma
oxygen
concentr
ml
per
decilit
tissu
rest
extract
ml
oxygen
per
decilit
blood
assum
normal
perfus
administ
percent
oxygen
ambient
pressur
increas
amount
oxygen
dissolv
blood
ml
per
decilit
atmospher
dissolvedoxygen
content
approxim
ml
per
decilit
latter
level
adequ
meet
rest
cellular
requir
without
contribut
oxygen
bound
hemoglobin
hbot
may
provid
novel
mean
treatingamelior
respiratori
condit
associ
theoret
possibl
therapi
may
potenti
provid
adequ
blood
oxygen
level
almost
complet
absenc
lungblood
interact
current
estim
hospit
us
offer
hbot
servic
medicar
cover
hbot
dozen
condit
result
present
exist
largescal
infrastructur
administ
hbot
patient
previous
describ
pack
red
blood
cell
prbc
transfus
mean
enhanc
intravascular
oxygencarri
capabl
thu
increas
oxygen
tissu
within
bodi
number
previou
studi
demonstr
prbc
transfus
result
signific
increas
oxygen
variou
bodi
tissu
prbc
transfus
may
provid
anoth
novel
mean
treatingamelior
respiratori
condit
associ
theoret
possibl
therapi
may
significantli
increas
blood
oxygen
level
prbc
transfus
common
medic
procedur
especi
among
patient
receiv
critic
care
among
patient
diagnos
previous
estim
patient
admit
icu
receiv
prbc
transfus
mean
unit
per
patient
widespread
avail
prbc
provid
mean
abl
rapidli
effici
transfus
patient
kidney
produc
erthropoietin
epo
circul
hormon
stimul
erythropoiesi
product
rbc
bind
activ
epo
receptor
epor
erythroid
progenitor
cell
clone
epo
gene
allow
develop
treatment
stimul
erthropoiesi
erthropoiesisstimul
agent
esa
esa
given
inject
observ
significantli
increas
number
rbc
increas
tissu
perfus
oxygen
sever
week
addit
given
abil
esa
increas
rbc
synthesi
observ
suppli
iron
may
abl
keep
pace
rbc
synthesi
henc
may
necessari
provid
iron
supplement
present
multipl
form
esa
avail
us
market
defin
differ
glycosyl
pattern
give
rise
alpha
beta
delta
omega
form
esa
cover
medicar
widespread
avail
esa
provid
anoth
mean
abl
rapidli
effici
treat
patient
chloroquinehydroxychloroquin
treatment
recent
suggest
chloroquin
cq
hydroxychloroquin
hcq
may
use
treatment
present
inadequ
evid
support
safe
effect
treatment
emerg
evid
suggest
cq
hcq
may
directli
impact
cornaviru
attach
respiratori
cell
also
interest
potenti
mode
action
drug
respect
respiratori
condit
associ
name
reveal
cq
hcq
abil
significantli
increas
cellular
hemoglobin
product
suggest
drug
may
therapeut
potenti
rais
hemoglobin
level
patient
addit
recent
metaanalysi
clinic
trial
reveal
hcq
treatment
among
patient
diagnos
diabet
mellitu
significantli
reduc
level
hemoglobin
glycat
hemoglobin
decreas
oxygen
carri
capac
limit
oxygen
tissu
deliveri
result
cq
hcq
treatment
may
help
improv
respiratori
condit
relat
mechan
consist
variou
previous
consid
treatment
also
recent
suggest
acetazolamid
may
use
treatment
respiratori
condit
patient
acetazolamid
carbon
anhydras
inhibitor
carbon
anhydras
found
proxim
tubul
kidney
allow
reabsorpt
bicarbon
sodium
chlorid
acetazolamid
inhibit
reabsorpt
ion
henc
increas
blood
level
bicarbon
blood
becom
acid
result
compensatori
hyperventil
kussmaul
respir
increas
blood
oxygen
level
decreas
blood
carbon
dioxid
level
result
acetazolamid
treatment
may
help
improv
respiratori
condit
relat
mechan
consist
variou
previous
consid
treatment
conclus
appar
global
diseas
associ
signific
morbid
mortal
signific
percentag
mortal
associ
relat
respiratori
condit
present
respiratori
ventil
support
standard
therapeut
treatment
respiratori
condit
associ
unfortun
despit
treatment
patient
respiratori
condit
high
mortal
rate
still
observ
hypothes
underli
patholog
chang
among
patient
compat
ard
seri
altern
treatment
strategi
util
clinic
avail
treatment
hbot
prbc
transfus
esa
hypothes
deliv
increas
oxygen
peripher
tissu
altern
mean
standard
respiratori
ventil
support
therapeut
treatment
fig
provid
overview
mechan
action
variou
novel
treatment
strategi
respiratori
condit
fig
summari
hemoglobinbas
deliveri
oxygen
molecul
peripher
tissu
normal
patient
capillari
patient
capillari
hb
hemoglobin
oxygen
sao
arteri
oxygen
satur
svo
venou
oxygen
satur
oxygen
tension
tissu
dedict
whether
one
sever
oxygen
molecul
releas
oxyhemoglobin
hbo
diffus
capillari
pink
area
tissu
fraction
hbo
rel
total
hb
arteri
blood
sao
normal
normal
mix
svo
decreas
svo
usual
indic
low
tissu
oxygen
tension
result
increas
extract
oxygen
molecul
hb
patient
recommend
given
altern
therapi
current
avail
routin
util
treatment
condit
therapi
tri
among
patient
seriou
respiratori
condit
also
recommend
futur
controlledclin
trial
explor
potenti
use
treatment
among
patient
respiratori
condit
fig
summari
novel
treatment
consid
improv
hemoglobinbas
deliveri
oxygen
molecul
peripher
tissu
patient
capillari
hb
hemoglobin
oxygen
hypothes
hyperbar
oxygen
therapi
significantli
increas
level
blood
independ
hb
level
improv
tissu
oxygen
also
hypothes
pack
red
blood
cell
transfus
inject
erthropoiesisstimul
agent
significantli
rais
blood
hb
level
increas
number
red
blood
cell
improv
tissu
oxygen
